Search
ATSN-101
go.drugbank.com/drugs/DB18327InvestigationalATSN-101 is a adeno-associated virus serotype 5 encoding human retinal guanylate cyclase 1 gene (AAV5-GUCY2D)
Phelimin
go.drugbank.com/drugs/DB18332ExperimentalPhelemin (PHE-MIP) is a methacrylic acid-based copolymer purified to bind to L-phenylalanine and L-phenylalanine-containing peptides.
Nendratareotide uzatansine
go.drugbank.com/drugs/DB18351InvestigationalNendratareotide uzatansine is a peptide-drug conjugate comprising a peptide analog of somatostatin conjugated to the cytotoxin mertansine.
E59
go.drugbank.com/drugs/DB18372ExperimentalE59 is a humanized IgG1 low affinity allergic reactivity inhibiting (LARI) monoclonal antibody. It was developed by Sixal Inc.
TORL-2-307
go.drugbank.com/drugs/DB18376ExperimentalTORL-2307 is a humanized immunoglobulin G1 (IgG1) monoclonal antibody (mAb) directed against claudin 18.2 (CLDN18.2) being investigated for the treatment of gastric and pancreatic cancer.
XTMAB-16
go.drugbank.com/drugs/DB18380InvestigationalXTMAB-16 is a monoclonal antibody directed against tumour necrosis factor-alpha (TNFα).
IVT-8086
go.drugbank.com/drugs/DB18381ExperimentalIVT-8086 is a humanized secreted frizzled-related protein-2 monoclonal antibody.
CAN-106
go.drugbank.com/drugs/DB18389InvestigationalCAN-106 a novel, long-acting monoclonal antibody directed against human complement C5.
LAVA-051
go.drugbank.com/drugs/DB18395InvestigationalLAVA-051 is a humanized Vγ9Vδ2-T cell-engaging bispecific antibody.
KP1237
go.drugbank.com/drugs/DB18401ExperimentalKP1237 is a antibody-redirecting molecule composed of two binding sites (a CD38 binder and a universal antibody binding terminus binder) connected by a linker chain.